Clinical Trial Update: BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 BATTLE program update reports results for Erlotinib in previously treated advanced non-small cell lung cancer, with the trial status completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-08-02